Form 4 for ADIL ADIAL PHARMACEUTICALS, INC.
Accepted 2026-04-09 17:00:07 ET · period of report 2026-04-07 · accession 0001213900-26-042052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-09 17:00 | 2026-04-07 | ADIL | Schuyler Kevin | Dir | A - Grant | $0.00 | +9,185 | 9,213 | +32,804% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-07 | A | A | 9,185 | $0.00 | 9,213 | D | — | — | (F1) Represents a grant of restricted shares of common stock that vest in full on the earlier of (i) the one-year anniversary of the grant date; or (ii) a Change of Control (as defined in the Issuer's 2017 Equity Incentive Plan, as amended), subject to the Reporting Person's continued service to the Issuer through the vesting date. |